Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stabilized Chlorine Dioxide Rinse for Peri-implant Mucositis
NCT04838054Phase 4Completed
- Sponsor
- Rowpar Pharmaceuticals
- Start
- Mar 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of CloSYS Oral Rinse in peri-implant mucositis (2 arms), sponsored by Rowpar Pharmaceuticals. Primary endpoints: Global Probing Depth at 90 days, Global Plaque Score at 90 days and 1 more. Started Mar 2018; status: completed.
02
Drugs
CloSYS Oral Rinse
03
Conditions
peri-implant mucositis
Beyond the preview
Go deeper on NCT04838054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04838054.